2013
DOI: 10.1167/iovs.12-11488
|View full text |Cite
|
Sign up to set email alerts
|

Tissue Transglutaminase Is a Negative Regulator of Monomeric Lacritin Bioactivity

Abstract: PURPOSE. Molar accounting of bioactive fluids can expose new regulatory mechanisms in the growing proteomic focus on epithelial biology. Essential for the viability of the surface epithelium of the eye and for normal vision is the thin, but protein-rich, tear film in which the small tear glycoprotein lacritin appears to play a prominent prosecretory, cytoprotective, and mitogenic role. Although optimal bioactive levels in cell culture are 1 to 10 nM over a biphasic dose optimum, ELISA suggests a sustained tear… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
43
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
7
2

Relationship

7
2

Authors

Journals

citations
Cited by 21 publications
(46 citation statements)
references
References 40 publications
3
43
0
Order By: Relevance
“…Interestingly, Lacrt displays growth factor-like behavior; however, its specificity for target cells of the ocular surface system results from a unique ‘off-on’ switch controlled by heparanase deglycanation of the cell surface protein, syndecan-1 [20], which both exposes and generates a Lacrt binding site [21] as a prerequisite for mitogenic signaling. Confirmed by 2-D electrophoresis, mass spectrometry and surface-enhanced laser desorption/ionization studies, Lacrt [22] is down regulated in blepharitis (chronic inflammation of the eyelid) vs. normal tears [23], and most aqueous deficient dry eye [24]. Whether down regulation of Lacrt provokes disease is a key unresolved question, but its prosecretory and corneal mitogenic activity suggest it might have activity as a protein therapeutic for ocular surface diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, Lacrt displays growth factor-like behavior; however, its specificity for target cells of the ocular surface system results from a unique ‘off-on’ switch controlled by heparanase deglycanation of the cell surface protein, syndecan-1 [20], which both exposes and generates a Lacrt binding site [21] as a prerequisite for mitogenic signaling. Confirmed by 2-D electrophoresis, mass spectrometry and surface-enhanced laser desorption/ionization studies, Lacrt [22] is down regulated in blepharitis (chronic inflammation of the eyelid) vs. normal tears [23], and most aqueous deficient dry eye [24]. Whether down regulation of Lacrt provokes disease is a key unresolved question, but its prosecretory and corneal mitogenic activity suggest it might have activity as a protein therapeutic for ocular surface diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Homeostatic dysregulation of the surface of the eye in "dry eye," a tear insufficiency syndrome(s) and the most common eye disease (12), offers some potential etiological clues because surprisingly few tear proteins show any disease-associated change. The only known growth factor-like molecule affected is lacritin (13)(14)(15)(16), a ϳ25-kDa prosecretory mitogen (17) also detected in saliva (18), plasma (19), and lung lavage (Human Proteinpedia HuPA_00022). Lacritin displays partial homology with dermcidin (20).…”
mentioning
confidence: 99%
“…Lacritin C-terminal bactericidal fragment is detectable in tears, is a product of recombinant lacritin production in E. coli, and is generated by S. epidermidis-and S. aureus-dependent proteolysis. A, increasing tear volumes were separated by SDS-PAGE, transferred, and blotted with anti-N-65 Lac C-terminal antibodies (ab C-term), revealing lacritin C-terminal fragments of 9, 10, and 12 kDa, glycosylated lacritin monomer (arrowhead), and higher molecular weight lacritin polymer (69). B, saturated overnight cultures of S. epidermidis were centrifuged, and supernatants were collected.…”
Section: Resultsmentioning
confidence: 99%